Equine protozoal myeloencephalitis

From WikiMD's WELLNESSPEDIA

Equine Protozoal Myeloencephalitis
Equine Protozoal Myeloencephalitis life cycle

Neurological disease in horses

Equine protozoal myeloencephalitis
ICD-10
ICD-9
DiseasesDB
MedlinePlus
eMedicine
MeSH ID

Equine protozoal myeloencephalitis (EPM) is a serious neurological disease affecting horses. It is caused by the protozoan parasites Sarcocystis neurona and, less commonly, Neospora hughesi. These parasites infect the central nervous system, leading to a range of neurological symptoms.

Symptoms[edit]

The clinical signs of EPM can vary widely, depending on the location of the lesions in the central nervous system. Common symptoms include:

Causes[edit]

EPM is primarily caused by the ingestion of Sarcocystis neurona sporocysts, which are shed in the feces of the definitive host, the Virginia opossum (Didelphis virginiana). Horses become infected by consuming feed or water contaminated with these sporocysts. Neospora hughesi is another protozoan that can cause EPM, though it is less common.

Diagnosis[edit]

Diagnosing EPM involves a combination of clinical signs, neurological examination, and diagnostic tests. Key diagnostic methods include:

Treatment[edit]

Treatment of EPM typically involves the use of antiprotozoal drugs such as ponazuril, diclazuril, or sulfadiazine combined with pyrimethamine. Additionally, anti-inflammatory drugs may be used to reduce inflammation and manage symptoms. Early diagnosis and treatment are crucial for a better prognosis.

Prevention[edit]

Preventive measures include:

  • Reducing exposure to opossums and their feces.
  • Implementing good feed and water management practices to avoid contamination.
  • Regularly cleaning and maintaining stables and feeding areas.

Related Pages[edit]

Categories[edit]


Equine_protozoal_myeloencephalitis[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.